Wednesday, 26 August 2026European Markets

BEAULIEU-AV. CERT Stock Is 16% Down In The Last 5 Sessions

Loading stream...

(VIANEWS) - Shares of BEAULIEU-AV. CERT (BEL 20: BEAB.BR) slid by a staggering 16.5% in 5 sessions from €5.15 to €4.30 at 20:08 EST on Thursday, following the last session's upward trend. BEL 20 is rising 0.99% to €3,807.06, following the last session's upward trend.

About BEAULIEU-AV. CERT

Immo-Beaulieu NV owns and operates real estate properties. The company is based in Brussels, Belgium. Immo-Beaulieu NV operates as a subsidiary of KBC Bank NV.

Volume

Today's last reported volume for BEAULIEU-AV. CERT is 30 which is 53.84% below its average volume of 65.

Volatility

BEAULIEU-AV. CERT's last week, last month's, and last quarter's current intraday variation average was a negative 10.29%, a negative 4.21%, and a positive 4.98%.

BEAULIEU-AV. CERT's highest amplitude of average volatility was 14.15% (last week), 6.59% (last month), and 4.98% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BEAULIEU-AV. CERT's stock is considered to be overbought (>=80).

More news about BEAULIEU-AV. CERT (BEAB.BR).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com